Amyotrophic Lateral Sclerosis - PowerPoint PPT Presentation

About This Presentation
Title:

Amyotrophic Lateral Sclerosis

Description:

Ali Nasim MD Fellow, Neuroradiology Division at UNC What is ALS? A-myo-trophic = no-muscle-nourishment Lateral Sclerosis refers to involvement of the lateral ... – PowerPoint PPT presentation

Number of Views:513
Avg rating:3.0/5.0
Slides: 23
Provided by: ajnrblogO
Learn more at: https://www.ajnrblog.org
Category:

less

Transcript and Presenter's Notes

Title: Amyotrophic Lateral Sclerosis


1
Amyotrophic Lateral Sclerosis
  • Ali Nasim MD
  • Fellow, Neuroradiology Division at UNC

2
What is ALS?
  • A-myo-trophic no-muscle-nourishment
  • Lateral Sclerosis refers to involvement of the
    lateral corticospinal tracts.
  • ALS is a degeneration of somatic motor neurons
    extending from upper motor cortical pyramidal
    neurons to lower motor neurons of the brainstem
    and cord.

3
History of ALS
  • 1869 - First described in publication by Dr.
    Jean-Martin Charcot, in Paris.
  • 1881 - Lectures translated into English

4
ALS Clinical Findings
  • Symptoms
  • Upper motor - Babinski, spasticity,
    hyperreflexia.
  • Lower motor - asymmetric muscle weakness,
    atrophy, fasciculations
  • Bulbar signs - dysphagia, slurred speech

5
ALS Clinical Findings
  • Types
  • Classic - UMN and LMN
  • Only UMN or only LMN
  • Predominantly bulbar form - worse prognosis
  • Familial - 15-20
  • 5600 cases per year in the US, 40-70 y/o, MF
    21

6
ALS Clinical Findings
  • Progresses distal to proximal, with complete
    disability within 10 yrs
  • 20 of patients survive gt5 yrs
  • Familial and juvenile onset survive 20-30 yrs
    after diagnosis

7
ALS Clinical Findings
  • Revised El Escorial World Federation of
    Neurology criteria
  • Evidence of LMN degeneration by clinical,
    electrophysiological, or neuropathological
    examination
  • Evidence of UMN degeneration by clinical
    examination
  • Progressive spread of symptoms or signs within a
    region or to other regions (The body is divided
    into four regions cranial, cervical, thoracic
    and lumbosacral)
  • Absence of electrophysiological, pathological or
    neuroimaging evidence of other disease processes.

8
ALS Imaging Findings
  • Can have normal imaging
  • Focal atrophy in chronic cases
  • T2/FLAIR hyperintensity extending along the
    corticospinal tract from corona radiata to the
    brainstem
  • Contrast enhancement - ?
  • Deposition of iron in affected cortex

9
ALS Imaging Findings
Early unilateral (left) ALS involvement in a
patient with associated callosal agenesis.
10
ALS Imaging Findings
Curved MPR Corticospinal Tract extension
11
ALS Imaging Findings
Enhancement is atypical but occasionally seen.
12
ALS Imaging Findings
Bilateral high T2 signal in corticospinal tracts.
13
ALS Imaging Findings
Increased iron (low T2 signal) deposition in the
gray matter of the peri-Rolandic regions which
underlying high signal in the white matte and
dilatation of the adjacent cortical sulci.
14
ALS Imaging Findings
FLAIR images shows high signal in the
cortico-spinal tracts due to Wallerian
degeneration.
15
ALS Imaging Findings
  • MR Spectroscopy
  • Decreased NAA/Cr ratio
  • Increased choline and myoinositol
  • Decreased glutamate in the precentral gyrus and
    peri-rolandi white matter

16
ALS Pathology
  • Loss of cortical pyramidal motor neurons and
    gliosis
  • Corticospinal tracts with variable patterns of
    degeneration
  • Precentral gyrus atrophy

17
ALS Pathophyiology
  • Cause of Spontaneous ALS unknown
  • Single gene mutations can lead to selective
    motor neuron loss
  • Glutamate excitotoxicity (etiology unknown)

18
ALS Pathophyiology
  • Familial ALS
  • Copper/Zinc Superoxide dismutase (SOD1)gene
    mutation found to be associated with 20 of
    familial ALS
  • Gain of function mutation

19
ALS Interesting Info
  • Reports of populations with increased incidence,
    most notably the Chamarro people of Guam
    (ALS-PCD)
  • Incidence ranging 140-400 cases / 100,000 (nml
    0.5-2 cases/ 100,00)
  • Recent theory is that this was due to bat
    consumption and exposure to BMMA excitotoxins.

20
ALS Notable People Affected
Lou Gehrig Stephen Hawking Jon
Stone
21
ALS Treatment
  • Riluzole - glutamate release inhibitor
  • -Has been shown to increase NAA/Cr ratio
  • Symptom treatment - ventilation, anti-spastic
    medications

22
References
  • Kalra, S. et al, Neuroimaging in Amyotrophic
    Lateral Sclerosis. ALS and Other Motor Neuron
    Disorders. 20034 243-248.
  • Kalra, S. et al, Gabapentin Therapy for
    Amyotrophic Lateral Sclerosis Lack of
    Improvement in Neuronal Integrity Shown by MR
    Spectroscopy AJNR, Mar 2003 24 476 - 480.
  • Bowen, B. , MR Imaging and Localized Proton
    Spectroscopy of the Precentral Gyrus in
    Amyotrophic Lateral Sclerosis AJNR, Apr 2000
    21 647 - 658.
  • statDx.com
  • archives.org
  • athiestnexus.org
  • sabine.k12.la.us
  • muppet.wikia.com
Write a Comment
User Comments (0)
About PowerShow.com